Renal Cell Carcinoma: New Developments in Molecular Biology and Potential for Targeted Therapies-Reference-Cited by-同舟云学术

Renal Cell Carcinoma: New Developments in Molecular Biology and Potential for Targeted Therapies

Published:2007-12-01 Issue:12 Volume:12 Page:1404-1415
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Costa Luciano J.¹,Drabkin Harry A.²

Affiliation:

1. a University of Colorado Health Sciences Center, Denver, Colorado, USA

2. b Medical University of South Carolina, Division of Hematology-Oncology, Charleston, South Carolina, USA

Abstract

Learning Objectives After completing this course, the reader will be able to: List the most frequent genetic abnormalities involved in RCC and explain how they lead to abnormal response to hypoxia, cell survival, and angiogenesis.Interpret the current literature concerning the treatment of RCC, and correlate therapeutic agents with their targets and underlying biological processes that drive the disease.Identify the limitations of current agents used in the treatment of RCC and the challenges that need to be overcome in developing therapies to improve the outcome of patients with advanced disease. Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.12-12-1404

Reference99 articles.

1. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006

2. Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: A review;Moore;Cancer Invest,2005

3. The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing;Kaelin;Biochem Biophys Res Commun,2005

4. Differential gene regulation of StarD4 and StarD5 cholesterol transfer proteins. Activation of StarD4 by sterol regulatory element-binding protein-2 and StarD5 by endoplasmic reticulum stress;Soccio;J Biol Chem,2005

5. Role of VHL gene mutation in human cancer;Kim;J Clin Oncol,2004

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumoricidal Activity of Simvastatin in Synergy with RhoA Inactivation in Antimigration of Clear Cell Renal Cell Carcinoma Cells;International Journal of Molecular Sciences;2023-06-04

2. PIK3R5 genetic predictors of hypertension induced by VEGF-pathway inhibitors;The Pharmacogenomics Journal;2021-11-13

3. Anti-relapse targeted chemoembolization as an adjunct to kidney cancer resection;Yakut Medical Journal;2021

4. What is the optimum systemic treatment for advanced/metastatic renal cell carcinoma of favourable, intermediate and poor risk, respectively? A systematic review and network meta-analysis;BMJ Open;2020-08

5. 15-Deoxy-Δ^12,14-prostaglandin J₂ Inhibits Cell Migration on Renal Cell Carcinoma via Down-Regulation of Focal Adhesion Kinase Signaling;Biological and Pharmaceutical Bulletin;2020-01-01